These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39068752)

  • 1. RACGAP1 is a pivotal gene in lung adenocarcinoma-associated membranous nephropathy: Based on comprehensive bioinformatics analysis and machine learning.
    Xu Q; Li J; Zhuo L; Gao H; Yang Y; Li W
    Int Immunopharmacol; 2024 Sep; 139():112783. PubMed ID: 39068752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma.
    Li Y; Cai Y; Ji L; Wang B; Shi D; Li X
    PeerJ; 2024; 12():e17746. PubMed ID: 39071134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
    Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
    BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma.
    Jin D; Song Y; Chen Y; Zhang P
    Biomed Res Int; 2020; 2020():7573689. PubMed ID: 32149133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
    Dai JJ; Zhou WB; Wang B
    Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
    Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G
    Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of biomarkers in membranous nephropathy and pan-cancer analysis.
    Yang Y; Zou GM; Wei XS; Zhang Z; Zhuo L; Xu QQ; Li WG
    Front Immunol; 2024; 15():1302909. PubMed ID: 38846934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated multi-omic analysis and experiment reveals the role of endoplasmic reticulum stress in lung adenocarcinoma.
    Liu Y; Lin W; Qian H; Yang Y; Zhou X; Wu C; Pan X; Liu Y; Wang G
    BMC Med Genomics; 2024 Jan; 17(1):12. PubMed ID: 38167084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hub genes and their correlation with immune infiltrating cells in membranous nephropathy: an integrated bioinformatics analysis.
    Han M; Wang Y; Huang X; Li P; Liang X; Wang R; Bao K
    Eur J Med Res; 2023 Nov; 28(1):525. PubMed ID: 37974210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
    Xu S; Zhou J; Liu K; Chen Z; He Z
    Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.